The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
* This Week in the Journal
 March 30, 2006
 Audio Icon Audio Summary
*
Correspondence
* Lethal Avian Influenza A (H5N1) Infection in a Pregnant Woman in Anhui Province, China
* Influenza Vaccination and False Positive HIV Results
* Oseltamivir Resistance in Influenza A (H5N1) Infection
* Infliximab for Ulcerative Colitis
* Clinical Trials Report Card
* Community-Acquired Bacterial Meningitis
* Case 37-2005: A Man with Cardiac Arrest while Sleeping
* Medical Mystery: Concentric Calcification — The Answer
*
Book Reviews
* Thurlbeck's Pathology of the Lung
* Physiologic Basis of Respiratory Disease
* Dyspnea: Mechanisms, Measurement, and Management
* Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies
Original Articles
An Avian Influenza Vaccine

This trial involving 451 healthy adults assessed responses to two intramuscular doses of a subvirion H5N1 influenza vaccine. At the highest dose (90 µg of hemagglutinin), 54 percent of the subjects had neutralization antibody titers of 1:40 or greater. The subvirion vaccine did not cause severe side effects, and in most subjects, it generated neutralizing-antibody responses typically associated with protection against influenza. A conventional subvirion H5 influenza vaccine may be effective in preventing influenza A (H5N1) disease (avian influenza) in humans.

Related Editorial


Original Articles
Outpatient Gatifloxacin Therapy and Dysglycemia

Gatifloxacin has been associated with both hypoglycemia and hyperglycemia. This study examined dysglycemia-related health outcomes associated with the use of various antibiotics in adults 66 years of age or older in Ontario, Canada. As compared with the use of other broad-spectrum oral antibiotics, including other fluoroquinolones, gatifloxacin use among outpatients appears to be clearly associated with both subsequent hypoglycemia and subsequent hyperglycemia.

Related Editorial


Original Articles
Monoclonal Gammopathy of Undetermined Significance

Serum from almost 80 percent of the residents of Olmsted County, Minnesota, was screened for the presence of a monoclonal gammopathy of undetermined significance. Small amounts of monoclonal immunoglobulin were found in 3.2 percent of persons 50 years of age or older and in 5.3 percent of persons 70 years of age or older.


Original Articles
Brief Report: Genetic Association between Epilepsy and Developmental Regression

This study reports the association of a mutant form of contactin-associated protein-like 2 (CASPR2) and epilepsy, cortical dysplasia, and developmental decay among children in an Old Order Amish population. It suggests that mutant CASPR2 causes epilepsy and influences cortical architecture.


Special Article
Behavioral Health Insurance Parity for Federal Employees

To improve insurance coverage of mental health and substance-abuse services, the Federal Employees Health Benefits Program required parity between behavioral health and general medical benefits beginning in January 2001. This study found that the parity policy was not associated with an increase in the use of behavioral health services or an increase in spending for patients who used these services.

Related Editorial


Review Article
Mechanisms of Disease: Hereditary Proteinuria Syndromes

This review summarizes recent advances in our knowledge of the glomerular filter and the causes of hereditary proteinuria syndromes.


Case Records of the Massachusetts General Hospital
A Woman with Barrett's Esophagus and High-Grade Dysplasia

A 66-year-old woman was found to have Barrett's esophagus with high-grade dysplasia and focal intramucosal adenocarcinoma. Her morbid obesity made her a poor candidate for esophagectomy. A pathologist and a gastroenterologist discuss the pathophysiology and management of Barrett's esophagus.


Clinical Implications of Basic Research
Targeting Rickettsia

A recent study identifies molecular events pivotal to infection by Rickettsia conorii.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.